The Lancet Respiratory Medicine in conversation with
A podcast by The Lancet Group
156 Episoade
-
Inhaled budesonide in the treatment of early COVID-19
Publicat: 15.04.2021 -
Tocilizumab and COVID-19
Publicat: 05.03.2021 -
Interferon treatment and COVID-19
Publicat: 06.02.2021 -
Evaluating deterioration in patients with acute COVID-19
Publicat: 12.01.2021 -
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Publicat: 05.01.2021 -
COVID-19 and severe influenza
Publicat: 18.12.2020 -
The second wave and homeless populations
Publicat: 11.11.2020 -
Corticosteroids, COPD, asthma and COVID-19
Publicat: 25.09.2020 -
Novel strategies to drive down the global burden of asthma
Publicat: 08.09.2020 -
The pathology of suspected EVALI
Publicat: 05.08.2020 -
Wheezing illness and RSV-LRTI
Publicat: 17.07.2020 -
Antibiotic use in infancy and asthma incidence
Publicat: 16.03.2020 -
Guidance on the development of prediction models for critical care
Publicat: 12.03.2020 -
Potential exacerbations in patients with COPD
Publicat: 03.03.2020 -
CPAP and mild obstructive sleep apnea
Publicat: 28.11.2019 -
An algorithm for EVALI
Publicat: 08.11.2019 -
Lung transplants from Hepatitis C viremic donors
Publicat: 05.10.2019 -
Looking to the future of cystic fibrosis care
Publicat: 29.09.2019 -
Pamrevlumab and idiopathic pulmonary fibrosis
Publicat: 27.09.2019 -
Nicotine patches, e-cigarettes, and smoking cessation
Publicat: 10.09.2019
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
